Aemetis (AMTX) Q1 2026 earnings summary
Event summary combining transcript, slides, and related documents.
Q1 2026 earnings summary
13 May, 2026Executive summary
Revenue grew 27% year-over-year to $54.6 million, driven by gains in all operating segments and the first-time recognition of Section 45Z production tax credits as revenue.
Gross profit turned positive at $2.8 million, reversing a $5.1 million loss in Q1 2025, mainly due to lower corn costs, increased biodiesel sales, and tax credit income.
Operating loss improved by 60% to $6.3 million from $15.6 million, and net loss narrowed to $21.7 million from $24.5 million year-over-year.
Adjusted EBITDA improved to negative $1.3 million from negative $10.7 million in Q1 2025.
Major capital projects advanced, including dairy biogas pretreatment and the $40 million MVR project at the Keyes ethanol plant.
Financial highlights
California Ethanol segment revenue rose 2.9% to $38.8 million; gross profit improved to $0.6 million from a loss.
Dairy RNG sales volume increased 55% to 110,000 MMBtu, with revenue more than doubling to $5.3 million.
India Biodiesel revenue rebounded to $10.5 million, up 291%, with gross profit of $0.1 million.
Section 45Z Production Tax Credits contributed $4.0 million in Q1 2026.
Cash and equivalents stood at $4.8 million at quarter-end; total debt increased to $404.7 million.
Outlook and guidance
Focus for 2026 is on scaling production, monetizing renewable fuel credits, completing the India IPO, and refinancing debt.
Key catalysts include the updated 45ZCF-GREET model, MVR commissioning, rising LCFS prices, and India IPO progress.
RNG segment to expand with new digesters and expects higher LCFS credit prices due to regulatory changes.
Substantial doubt remains about ability to continue as a going concern due to high debt and negative cash flow.
Latest events from Aemetis
- Proxy seeks votes on director election and auditor ratification, with emphasis on governance and compensation.AMTX
Proxy filing7 Apr 2026 - Dairy RNG output soared, losses narrowed, and investments and policy wins set up 2026 growth.AMTX
Q4 202512 Mar 2026 - Q2 revenue up 48% to $66.6M, but net loss widened and liquidity concerns persist.AMTX
Q2 20242 Feb 2026 - Board approves executive bonuses, $80M share buyback, and charter amendments for share structure.AMTX
Proxy Filing28 Jan 2026 - Q3 2024 revenue up 19% to $81.4M, but net loss and liquidity risks remain.AMTX
Q3 202414 Jan 2026 - Stockholders to vote on key changes to capital structure and meeting procedures, with Board support.AMTX
Proxy Filing31 Dec 2025 - Revenue up 43% to $268M, but net loss widened; policy and tax credits to drive future growth.AMTX
Q4 202426 Dec 2025 - Votes sought to amend capital structure and empower Board for future growth and flexibility.AMTX
Proxy Filing19 Dec 2025 - Up to $234 million in securities may be offered amid ongoing losses and risk disclosures.AMTX
Registration Filing16 Dec 2025